Results 91 to 100 of about 69,426 (314)

Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT In recent years, innovative topical medications with novel mechanisms of action have emerged to treat common dermatologic conditions such as acne, atopic dermatitis, vitiligo, and actinic keratoses. These molecularly targeted therapies offer improved safety and tolerability compared to traditional options like corticosteroids.
Mary Dyson   +4 more
wiley   +1 more source

Pharmacovigilance Knowledge, Attitudes, and Practices Among Healthcare Professionals in Nepal: A Systematic Review. [PDF]

open access: yesHealth Sci Rep
ABSTRACT Background and Aims Healthcare professionals' (HCPs') knowledge, attitude, and practice (KAP) regarding pharmacovigilance (PV) remains underexplored in Nepal. This systematic review aims to assess the current state of KAP of PV among HCPs in Nepal, identify existing gaps, and propose interventions to strengthen the PV system.
Pathak N   +6 more
europepmc   +2 more sources

Terminology Extraction for and from Communications in Multi-disciplinary Domains [PDF]

open access: yes, 2016
Terminology extraction generally refers to methods and systems for identifying term candidates in a uni-disciplinary and uni-lingual environment such as engineering, medical, physical and geological sciences, or administration, business and leisure ...
Ahmad, Khurshid   +3 more
core  

Dermatological Manifestations of Glucagon‐Like Peptide‐1 Receptor Agonists

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‑1 RAs) play a pivotal role in treating type 2 diabetes. Despite their widespread use, their dermatological manifestations remain under‐recognized, hence the interest of this systematic review. Objectives This systematic review aims to assess dermatological manifestations associated with
Nour Ghostine, Maya Halabi‐Tawil
wiley   +1 more source

Classification of existing problems in the Russian pharmacovigilance system

open access: yesСеченовский вестник, 2018
The pharmacovigilance system currently represents as a complex of interstate, state, departmental and public institutions. This system provides the receipt and processing of information about facts and circumstances that pose a threat to life or health ...
B. K. Romanov, A. E. Krasheninnikov
doaj   +1 more source

Doprinos novoga farmakovigilancijskoga zakonodavstva EU-a u zaštiti zdravlja [PDF]

open access: yes, 2016
Cilj istraživanja: Cilj ovog rada bio je istražiti doseg današnje farmakovigilancije, odnosno utjecaj nove farmakovigilancijske legislative Europske unije na praćenja sigurnosnog profila lijeka, a ponajviše njezin doprinos zaštiti zdravlja pacijenta ...
Mihalić, Maša
core   +1 more source

Pharmacovigilance [Pharmacovigilance update]

open access: yes, 2008
The observations of pharmacovigilance reported during 2007 reflect an increasing attention towards drug-induced augmentation of the incidence of common disorders. New substances are thus to be added to the list of risk factors susceptible to favour cardiovascular events (tegaserod, rosiglitazone, erythropoïetin, aprotinine) or psychiatric disorders ...
Livio, F., Buclin, T., Biollaz, J.
openaire   +1 more source

Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT

open access: yesObesity, EarlyView.
ABSTRACT Objective This post hoc analysis assessed psychiatric changes with tirzepatide in adults with obesity, without known major psychopathology, from SURMOUNT‐1, SURMOUNT‐2, and SURMOUNT‐3. Methods In participants (N = 4056) treated with tirzepatide (5/10/15 mg or maximum tolerated dose 10/15 mg) versus placebo, depressive symptoms and suicidal ...
Thomas A. Wadden   +6 more
wiley   +1 more source

Pharmacovigilance

open access: yesInternational Journal of Risk & Safety in Medicine, 2015
Antoine Pariente, Yola Moride
  +6 more sources

Home - About - Disclaimer - Privacy